Overview

Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks

Status:
Completed

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

Summary

Assessment of treatment success and quality of life in patients with actinic keratoses under therapy with Ingenol Mebutate (Picato) in a period of 8 weeks.

Details

Lead Sponsor:

LEO Pharma